Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma

OncoImmunology

Volumn 5, Issue 10, 2016, Pages

  He, Min ^a   Peng, Anping ^a   Huang, Xian Zhang ^a   Shi, Dai Chao ^b   Wang, Jun Cheng ^b   Zhao, Qiyi ^c   Lin, Haibiao ^a   Kuang, Dong Ming ^b   Ke, Pei Feng ^a   Lao, Xiang Ming ^b  

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

c Met; HCC; hepatocyte growth factor; metastasis; tumor neutrophils

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B BETA; RETROVIRUS VECTOR; SCATTER FACTOR RECEPTOR; STRESS ACTIVATED PROTEIN KINASE;

ADULT; AGED; ANIMAL CELL; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OVERALL SURVIVAL; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR GROWTH;

EID: 84991037817     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2016.1219828     Document Type: Article

References (47)

1. D.M.Kuang, X.Xiao, Q.Zhao, M.M.Chen, X.F.Li, R.X.Liu, Y.Wei, F.Z.Ouyang, D.P.Chen, Y.Wu et al. B7-H1-expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets. J Clin Invest 2014; 124:4657-67; PMID:25244097; http://dx.doi.org/10.1172/JCI74381
2. I.Kryczek, Y.Lin, N.Nagarsheth, D.Peng, L.Zhao, E.Zhao, L.Vatan, W.Szeliga, Y.Dou, S.Owens et al. IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. Immunity 2014; 40:772-84; PMID:24816405; http://dx.doi.org/10.1016/j.immuni.2014.03.010
3. R.X.Liu, Y.Wei, Q.H.Zeng, K.W.Chan, X.Xiao, X.Y.Zhao, M.M.Chen, F.Z.Ouyang, D.P.Chen, L.Zheng et al. Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma. Hepatology 2015; 62:1779-90; PMID:26235097; http://dx.doi.org/10.1002/hep.28020
4. X.Xiao, X.M.Lao, M.M.Chen, R.X.Liu, Y.Wei, F.Z.Ouyang, D.P.Chen, X.Y.Zhao, Q.Zhao, X.F.Li et al. PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Cancer Discov 2016; 6:546-59; PMID:26928313; http://dx.doi.org/10.1158/2159-8290.CD-15-1408
5. Y.Wu, D.M.Kuang, W.D.Pan, Y.L.Wan, X.M.Lao, D.Wang, X.F.Li, L.Zheng. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Hepatology 2013; 57:1107-16; PMID:23225218; http://dx.doi.org/10.1002/hep.26192
6. J.Fu, Z.Zhang, L.Zhou, Z.Qi, S.Xing, J.Lv, J.Shi, B.Fu, Z.Liu, J.Y.Zhang et al. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma. Hepatology 2013; 58:139-49; PMID:22961630; http://dx.doi.org/10.1002/hep.26054
7. H.Wang, B.Gao. MicroRNAs control hepatocarcinogenesis by regulating hepatocyte nuclear factor 4alpha-inflammatory signal feedback loops. Hepatology 2014; 60:1466-8; PMID:24996014; http://dx.doi.org/10.1002/hep.27287
8. S.Su, Q.Zhao, C.He, D.Huang, J.Liu, F.Chen, J.Chen, J.Y.Liao, X.Cui, Y.Zeng et al. miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat Commun 2015; 6:8523; PMID:26436920; http://dx.doi.org/10.1038/ncomms9523
9. Q.Zhao, X.Xiao, Y.Wu, Y.Wei, L.Y.Zhu, J.Zhou, D.M.Kuang. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients. Eur J Immunol 2011; 41:2314-22; PMID:21674477; http://dx.doi.org/10.1002/eji.201041282
10. D.M.Kuang, Q.Zhao, C.Peng, J.Xu, J.P.Zhang, C.Wu, L.Zheng. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 2009; 206:1327-37; PMID:19451266; http://dx.doi.org/10.1084/jem.20082173
11. D.M.Kuang, C.Peng, Q.Zhao, Y.Wu, L.Y.Zhu, J.Wang, X.Y.Yin, L.Li, L.Zheng. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J Immunol 2010; 185:1544-9; PMID:20581151; http://dx.doi.org/10.4049/jimmunol.0904094
12. G.Y.Liou, H.Doppler, B.Necela, B.Edenfield, L.Zhang, D.W.Dawson, P.Storz. Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. Cancer Discov 2015; 5:52-63; PMID:25361845; http://dx.doi.org/10.1158/2159-8290.CD-14-0474
13. M.P.Smith, B.Sanchez-Laorden, K.O'Brien, H.Brunton, J.Ferguson, H.Young, N.Dhomen, K.T.Flaherty, D.T.Frederick, Z.A.Cooper et al. The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFalpha. Cancer Discov 2014; 4:1214-29; PMID:25256614; http://dx.doi.org/10.1158/2159-8290.CD-13-1007
14. Y.Wu, Q.Zhao, C.Peng, L.Sun, X.F.Li, D.M.Kuang. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol 2011; 225:438-47; PMID:21826665; http://dx.doi.org/10.1002/path.2947
15. A.Mantovani, M.A.Cassatella, C.Costantini, S.Jaillon. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011; 11:519-31; PMID:21785456; http://dx.doi.org/10.1038/nri3024
16. C.Nathan. Neutrophils and immunity:challenges and opportunities. Nat Rev Immunol 2006; 6:173-82; PMID:16498448; http://dx.doi.org/10.1038/nri1785
17. M.G.Manz, S.Boettcher. Emergency granulopoiesis. Nat Rev Immunol 2014; 14:302-14; PMID:24751955; http://dx.doi.org/10.1038/nri3660
18. M.He, Z.Xu, T.Ding, D.M.Kuang, L.Zheng. MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta. Cell Mol Immunol 2009; 6:343-52; PMID:19887047; http://dx.doi.org/10.1038/cmi.2009.45
19. S.Tazzyman, H.Niaz, C.Murdoch. Neutrophil-mediated tumour angiogenesis:subversion of immune responses to promote tumour growth. Semin Cancer Biol 2013; 23:149-58; PMID:23410638; http://dx.doi.org/10.1016/j.semcancer.2013.02.003
20. E.M.Bekes, B.Schweighofer, T.A.Kupriyanova, E.Zajac, V.C.Ardi, J.P.Quigley, E.I.Deryugina. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol 2011; 179:1455-70; PMID:21741942; http://dx.doi.org/10.1016/j.ajpath.2011.05.031
21. D.M.Kuang, Q.Zhao, Y.Wu, C.Peng, J.Wang, Z.Xu, X.Y.Yin, L.Zheng. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol 2011; 54:948-55; PMID:21145847; http://dx.doi.org/10.1016/j.jhep.2010.08.041
22. X.F.Li, D.P.Chen, F.Z.Ouyang, M.M.Chen, Y.Wu, D.M.Kuang, L.Zheng. Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma. J Hepatol 2015; 62:131-9; PMID:25152203; http://dx.doi.org/10.1016/j.jhep.2014.08.023
23. Y.Gui, M.Yeganeh, S.Ramanathan, C.Leblanc, V.Pomerleau, G.Ferbeyre, C.Saucier, S.Ilangumaran. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes. J Hepatol 2011; 55:1300-8; PMID:21703184; http://dx.doi.org/10.1016/j.jhep.2011.03.027
24. S.Takeda, H.Liu, S.Sasagawa, Y.Dong, P.A.Trainor, E.H.Cheng, J.J.Hsieh. HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma. J Clin Invest 2013; 123:3154-65; PMID:23934123; http://dx.doi.org/10.1172/JCI65566
25. E.Gherardi, W.Birchmeier, C.Birchmeier, G.Vande Woude. Targeting MET in cancer:rationale and progress. Nat Rev Cancer 2012; 12:89-103; PMID:22270953; http://dx.doi.org/10.1038/nrc3205
26. F.Lordick. Targeting the HGF/MET pathway in gastric cancer. Lancet Oncol 2014; 15:914-6; PMID:24965570; http://dx.doi.org/10.1016/S1470-2045(14)70273-6
27. V.Finisguerra, G.Di Conza, M.Di Matteo, J.Serneels, S.Costa, A.A.Thompson, E.Wauters, S.Walmsley, H.Prenen, Z.Granot et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature 2015; 522:349-53; PMID:25985180; http://dx.doi.org/10.1038/nature14407
28. H.You, W.Ding, H.Dang, Y.Jiang, C.B.Rountree. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology 2011; 54:879-89; PMID:21618573; http://dx.doi.org/10.1002/hep.24450
29. B.Amulic, C.Cazalet, G.L.Hayes, K.D.Metzler, A.Zychlinsky. Neutrophil function:from mechanisms to disease. Annu Rev Immunol 2012; 30:459-89; PMID:22224774; http://dx.doi.org/10.1146/annurev-immunol-020711-074942
30. C.W.Hong, T.K.Kim, H.Y.Ham, J.S.Nam, Y.H.Kim, H.Zheng, B.Pang, T.K.Min, J.S.Jung, S.N.Lee et al. Lysophosphatidylcholine increases neutrophil bactericidal activity by enhancement of azurophil granule-phagosome fusion via glycine.GlyR alpha 2/TRPM2/p38 MAPK signaling. J Immunol 2010; 184:4401-13; PMID:20237295; http://dx.doi.org/10.4049/jimmunol.0902814
31. D.Martinez, M.Vermeulen, A.Trevani, A.Ceballos, J.Sabatte, R.Gamberale, M.E.Alvarez, G.Salamone, T.Tanos, O.A.Coso et al. Extracellular acidosis induces neutrophil activation by a mechanism dependent on activation of phosphatidylinositol 3-kinase/Akt and ERK pathways. J Immunol 2006; 176:1163-71; PMID:16394005; http://dx.doi.org/10.4049/jimmunol.176.2.1163
32. L.Dolcetti, E.Peranzoni, S.Ugel, I.Marigo, A.Fernandez Gomez, C.Mesa, M.Geilich, G.Winkels, E.Traggiai, A.Casati et al. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol 2010; 40:22-35; PMID:19941314; http://dx.doi.org/10.1002/eji.200939903
33. L.Trusolino, A.Bertotti, P.M.Comoglio. MET signalling:principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010; 11:834-48; PMID:21102609; http://dx.doi.org/10.1038/nrm3012
34. G.R.Blumenschein, Jr., G.B.Mills, A.M.Gonzalez-Angulo. Targeting the hepatocyte growth factor-cMET axis in cancer therapy. J Clin Oncol 2012; 30:3287-96; PMID:22869872; http://dx.doi.org/10.1200/JCO.2011.40.3774
35. A.Mantovani. The yin-yang of tumor-associated neutrophils. Cancer Cell 2009; 16:173-4; PMID:19732714; http://dx.doi.org/10.1016/j.ccr.2009.08.014
36. C.Murdoch, M.Muthana, S.B.Coffelt, C.E.Lewis. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008; 8:618-31; PMID:18633355; http://dx.doi.org/10.1038/nrc2444
37. A.Spiegel, M.W.Brooks, S.Houshyar, F.Reinhardt, M.Ardolino, E.Fessler, M.B.Chen, J.A.Krall, J.DeCock, I.K.Zervantonakis et al. Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. Cancer Discov 2016; 6:630-49; PMID:27072748; http://dx.doi.org/10.1158/2159-8290.CD-15-1157
38. M.M.Queen, R.E.Ryan, R.G.Holzer, C.R.Keller-Peck, C.L.Jorcyk. Breast cancer cells stimulate neutrophils to produce oncostatin M:potential implications for tumor progression. Cancer Res 2005; 65:8896-904; PMID:16204061; http://dx.doi.org/10.1158/0008-5472.CAN-05-1734
39. D.M.Kuang, Y.Wu, N.Chen, J.Cheng, S.M.Zhuang, L.Zheng. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 2007; 110:587-95; PMID:17395778; http://dx.doi.org/10.1182/blood-2007-01-068031
40. Q.Zhao, D.M.Kuang, Y.Wu, X.Xiao, X.F.Li, T.J.Li, L.Zheng. Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages. J Immunol 2012; 188:1117-24; PMID:22184722; http://dx.doi.org/10.4049/jimmunol.1100164
41. T.Lawrence, G.Natoli. Transcriptional regulation of macrophage polarization:enabling diversity with identity. Nat Rev Immunol 2011; 11:750-61; PMID:22025054; http://dx.doi.org/10.1038/nri3088
42. S.Gordon, F.O.Martinez. Alternative activation of macrophages:mechanism and functions. Immunity 2010; 32:593-604; PMID:20510870; http://dx.doi.org/10.1016/j.immuni.2010.05.007
43. S.Su, Q.Liu, J.Chen, F.Chen, C.He, D.Huang, W.Wu, L.Lin, W.Huang, J.Zhang et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 2014; 25:605-20; PMID:24823638; http://dx.doi.org/10.1016/j.ccr.2014.03.021
44. S.Corso, S.Giordano. Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies:from basic research to a clinical perspective. Cancer Discov 2013; 3:978-92; PMID:23901039; http://dx.doi.org/10.1158/2159-8290.CD-13-0040
45. C.C.Uphoff, H.G.Drexler. Detection of mycoplasma in leukemia-lymphoma cell lines using polymerase chain reaction. Leukemia 2002; 16:289-93; PMID:11840297; http://dx.doi.org/10.1038/sj.leu.2402365
46. L.Zheng, M.He, M.Long, R.Blomgran, O.Stendahl. Pathogen-induced apoptotic neutrophils express heat shock proteins and elicit activation of human macrophages. J Immunol 2004; 173:6319-26; PMID:15528371; http://dx.doi.org/10.4049/jimmunol.173.10.6319
47. D.M.Kuang, C.Peng, Q.Zhao, Y.Wu, M.S.Chen, L.Zheng. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 2010; 51:154-64; PMID:19902483; http://dx.doi.org/10.1002/hep.23291